Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1878 1
1899 1
1930 1
1933 1
1934 1
1935 1
1936 2
1937 2
1938 2
1939 3
1940 3
1941 3
1942 2
1945 1
1946 13
1947 2
1948 20
1949 18
1950 11
1951 8
1952 22
1953 4
1954 11
1955 17
1956 6
1957 10
1958 12
1959 10
1960 9
1961 5
1962 12
1963 8
1964 7
1965 15
1966 13
1967 8
1968 11
1969 7
1970 9
1971 15
1972 10
1973 15
1974 6
1975 15
1976 8
1977 12
1978 4
1979 9
1980 10
1981 5
1982 7
1983 10
1984 11
1985 11
1986 7
1987 2
1988 6
1989 10
1990 5
1991 11
1992 4
1993 7
1994 6
1995 8
1996 7
1997 8
1998 6
1999 7
2000 8
2001 12
2002 16
2003 15
2004 13
2005 14
2006 13
2007 21
2008 12
2009 9
2010 14
2011 17
2012 13
2013 20
2014 25
2015 17
2016 12
2017 13
2018 17
2019 26
2020 25
2021 45
2022 41
2023 27
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

945 results

Results by year

Filters applied: . Clear all
Page 1
IMI Prevention of Myopia and Its Progression.
Jonas JB, Ang M, Cho P, Guggenheim JA, He MG, Jong M, Logan NS, Liu M, Morgan I, Ohno-Matsui K, Pärssinen O, Resnikoff S, Sankaridurg P, Saw SM, Smith EL 3rd, Tan DTH, Walline JJ, Wildsoet CF, Wu PC, Zhu X, Wolffsohn JS. Jonas JB, et al. Among authors: smith el 3rd. Invest Ophthalmol Vis Sci. 2021 Apr 28;62(5):6. doi: 10.1167/iovs.62.5.6. Invest Ophthalmol Vis Sci. 2021. PMID: 33909032 Free PMC article. Review.
GPRC5D-Targeted CAR T Cells for Myeloma.
Mailankody S, Devlin SM, Landa J, Nath K, Diamonte C, Carstens EJ, Russo D, Auclair R, Fitzgerald L, Cadzin B, Wang X, Sikder D, Senechal B, Bermudez VP, Purdon TJ, Hosszu K, McAvoy DP, Farzana T, Mead E, Wilcox JA, Santomasso BD, Shah GL, Shah UA, Korde N, Lesokhin A, Tan CR, Hultcrantz M, Hassoun H, Roshal M, Sen F, Dogan A, Landgren O, Giralt SA, Park JH, Usmani SZ, Rivière I, Brentjens RJ, Smith EL. Mailankody S, et al. Among authors: smith el. N Engl J Med. 2022 Sep 29;387(13):1196-1206. doi: 10.1056/NEJMoa2209900. N Engl J Med. 2022. PMID: 36170501 Free PMC article. Clinical Trial.
Activation of Tumor-Cell STING Primes NK-Cell Therapy.
Knelson EH, Ivanova EV, Tarannum M, Campisi M, Lizotte PH, Booker MA, Ozgenc I, Noureddine M, Meisenheimer B, Chen M, Piel B, Spicer N, Obua B, Messier CM, Shannon E, Mahadevan NR, Tani T, Schol PJ, Lee-Hassett AM, Zlota A, Vo HV, Ha M, Bertram AA, Han S, Thai TC, Gustafson CE, Venugopal K, Haggerty TJ, Albertson TP, Hartley AV, Eser PO, Li ZH, Cañadas I, Vivero M, De Rienzo A, Richards WG, Abu-Yousif AO, Appleman VA, Gregory RC, Parent A, Lineberry N, Smith EL, Jänne PA, Miret JJ, Tolstorukov MY, Romee R, Paweletz CP, Bueno R, Barbie DA. Knelson EH, et al. Among authors: smith el. Cancer Immunol Res. 2022 Aug 3;10(8):947-961. doi: 10.1158/2326-6066.CIR-22-0017. Cancer Immunol Res. 2022. PMID: 35678717 Free PMC article.
IMI - Myopia Control Reports Overview and Introduction.
Wolffsohn JS, Flitcroft DI, Gifford KL, Jong M, Jones L, Klaver CCW, Logan NS, Naidoo K, Resnikoff S, Sankaridurg P, Smith EL 3rd, Troilo D, Wildsoet CF. Wolffsohn JS, et al. Among authors: smith el 3rd. Invest Ophthalmol Vis Sci. 2019 Feb 28;60(3):M1-M19. doi: 10.1167/iovs.18-25980. Invest Ophthalmol Vis Sci. 2019. PMID: 30817825 Free PMC article.
GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells.
Smith EL, Harrington K, Staehr M, Masakayan R, Jones J, Long TJ, Ng KY, Ghoddusi M, Purdon TJ, Wang X, Do T, Pham MT, Brown JM, De Larrea CF, Olson E, Peguero E, Wang P, Liu H, Xu Y, Garrett-Thomson SC, Almo SC, Wendel HG, Riviere I, Liu C, Sather B, Brentjens RJ. Smith EL, et al. Sci Transl Med. 2019 Mar 27;11(485):eaau7746. doi: 10.1126/scitranslmed.aau7746. Sci Transl Med. 2019. PMID: 30918115 Free PMC article.
IMI - Report on Experimental Models of Emmetropization and Myopia.
Troilo D, Smith EL 3rd, Nickla DL, Ashby R, Tkatchenko AV, Ostrin LA, Gawne TJ, Pardue MT, Summers JA, Kee CS, Schroedl F, Wahl S, Jones L. Troilo D, et al. Among authors: smith el 3rd. Invest Ophthalmol Vis Sci. 2019 Feb 28;60(3):M31-M88. doi: 10.1167/iovs.18-25967. Invest Ophthalmol Vis Sci. 2019. PMID: 30817827 Free PMC article. Review.
Reply.
Smith EL. Smith EL. Orthopedics. 2021 Sep-Oct;44(5):262-263. doi: 10.3928/01477447-20210819-11. Epub 2021 Sep 1. Orthopedics. 2021. PMID: 34590951 Free article. No abstract available.
Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape-Driven Relapse in Multiple Myeloma.
Fernández de Larrea C, Staehr M, Lopez AV, Ng KY, Chen Y, Godfrey WD, Purdon TJ, Ponomarev V, Wendel HG, Brentjens RJ, Smith EL. Fernández de Larrea C, et al. Among authors: smith el. Blood Cancer Discov. 2020 Sep;1(2):146-154. doi: 10.1158/2643-3230.BCD-20-0020. Blood Cancer Discov. 2020. PMID: 33089218 Free PMC article.
Myopia--yesterday, today, and tomorrow.
Mutti DO, Gwiazda J, Norton TT, Smith EL 3rd, Schaeffel F, To CH. Mutti DO, et al. Among authors: smith el 3rd. Optom Vis Sci. 2013 Nov;90(11):1161-4. doi: 10.1097/OPX.0000000000000117. Optom Vis Sci. 2013. PMID: 24152883 Free PMC article. No abstract available.
945 results